Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.
AUTOR(ES)
de Miranda, P
RESUMO
6-Methoxypurine arabinoside (ara-M) exhibits potent activity against varicella-zoster virus (VZV) as a result of ara-M's anabolism to the triphosphate of adenine arabinoside (ara-ATP) in VZV-infected cells. The adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) enhanced the formation of ara-ATP by inhibiting ara-M demethoxylation. In contrast, deoxycoformycin and coformycin, inhibitors of both adenosine deaminase and AMP deaminase, blocked the formation of ara-ATP and reversed the anti-VZV activity of ara-M. These results indicate that after the initial phosphorylation of ara-M by the VZV-coded thymidine kinase, the monophosphate is demethoxylated by AMP deaminase to form ara-IMP, which is converted to ara-ATP by the sequential actions of the cellular adenylosuccinate synthetase, adenylosuccinate lyase, and nucleotide kinases.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245337Documentos Relacionados
- Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells.
- 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
- Varicella-zoster virus.
- 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
- Induction of deoxypyrimidine kinase activity in human embryonic lung cells infected with varicella-zoster virus.
